US Graves' disease Market Growth, Trends, Analysis, Future Scope & Forecast to 2025

US Graves' disease market is growing at a CAGR of around 4.0% during the forecast period. The US Grave's disease market is showing significant growth due to funding for autoimmune disease researches, and the increasing prevalence of hyperthyroidism in the region. In addition, significant rise in the prevalence of autoimmune disease is also expected to propel the growth of the US Graves' disease market. According to the American Autoimmune Related Diseases Association, Inc. (AARDA), the number of Americans suffer from autoimmune disease is 50 million. This is approximately 20% of the total population or 1 in 5 people suffer from autoimmune disease. 75% of people that are affected with autoimmune disease, about 30 million are women.

Get Sample Copy of US Graves' disease Market at: https://www.omrglobal.com/request-sample/us-graves-disease-market

Key Players - Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd.

Furthermore, as per AARDA, NIH invests $591 million on autoimmune disease research. NIH supports companies in the development of therapies for the treatment of Grave's. For instance, in December 2017, EpiVax, Inc., a US-based biotech firm declared the latest program for novel antigen-specific therapies. The funding was provided by NIH for development of the therapy. This approach may have applications in various autoimmune diseases.

For More Information, get A full report of US Graves' disease Market is available at: https://www.omrglobal.com/industry-reports/us-graves-disease-market

Moreover, hyperthyroidism is the most common disease in the US. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), estimated 1.2% of people in the US have hyperthyroidism. The people that have other health problems, such as type 1 diabetes, primary adrenal insufficiency and pernicious anemia are likely to develop hyperthyroidism. The most common cause of hyperthyroidism is Grave's disease. According to Beyond Type 1, the prevalence of hypothyroidism due to Hashimoto's thyroiditis is anticipated to range from 4 to 19% of people with type 1 diabetes. The significant increase in incidences of type-1 diabetes increases the possibility of having Grave's disease and thereby contributing to the growth of the US Graves' disease market.

Market Segmentation

Graves' Disease Market by Diagnosis

o Ultrasound
o Imaging Tests
o Radioactive Iodine Uptake
o Blood Sample

Graves' Disease Market by Treatment

o Anti- Thyroid Medication
o Radioactive Iodine Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-graves-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.